Skip to main content

Table 1 Clinical and demographic characteristics of groups

From: Comprehensive left ventricular mechanics analysis by speckle tracking echocardiography in Chagas disease

Variables Chagas Controls
Ch1A (n = 8) Ch1B (n = 13) Ch2 (n = 17) Ch3 (n = 9) C1 (n = 58) C2 (n = 7) C3 (n = 19)
Age (y)a 56 ± 7c 54 ± 12c 56 ± 12 56 ± 9 37 ± 12 47 ± 9 50 ± 11
Gender Mb 1 (12 %) 4 (31 %) 8 (47 %) 3 (67 %) 25 (43 %) 3 (43 %) 10 (53 %)
Weight (Kg)a 66.3 ± 10.6 67.5 ± 12.5 68.3 ± 12.3 65.2 ± 8.6 73.1 ± 15.9 69.5 ± 14.6 69.8 ± 16.2
Height (cm)a 157 ± 12d 160 ± 10d 165 ± 8 162 ± 6 169 ± 9 162 ± 10 164 ± 12
BS (m2)a 1.66 ± 0.19 1.70 ± 0.18 1.64 ± 0.18 1.70 ± 0.12 1.83 ± 0.21 1.74 ± 0.21 1.75 ± 0.25
BMI (kg/m2)a 26.9 ± 3.5 26.6 ± 4.8 25.0 ± 3.0 24.8 ± 3.0 25.4 ± 4.1 26.2 ± 4.4 25.6 ± 3.9
SAHb 4 (50.0 %)e 5 (38.5 %)e 5 (29.4 %) 4 (44.4 %) 0 (0 %) 1 (14.3 %) 8 (42.1 %)
DMb 1 (12.5 %) 1 (7.7 %) 1 (5.9 %) 1 (11.1 %) 0 (0 %) 1 (14.3 %) 1 (5.3 %)
DLPb 2 (25.0 %)f 4 (30.8 %)f 4 (23.5 %) 4 (44.4 %) 1 (1.7 %) 1 (14.3 %) 4 (21.1 %)
Smokerb 0 (0 %) 0 (0 %) 0 (0 %) 1 (11.1 %) 0 (0 %) 0 (0 %) 0 (0 %)
FC CHF (NYHA)b
 I 1 (12.5 %)g 7 (53.8 %)g 11 (64.7 %) 5 (55.5 %) 0 (0 %) 3 (42.9 %) 11 (57.9 %)
 II 0 (0 %) 1 (7.7 %) 5 (29.4 %) 4 (44.4 %) 0 (0 %) 3 (42.9 %) 7 (36.8 %)
 III 0 (0 %) 0 (0 %) 1 (5.9 %) 0 (0 %) 0 (0 %) 1 (14.3 %) 1 (5.3 %)
 IV 0 (0 %) 0 (0 %) 0 (0 %) 0 (0 %) 0 (0 %) 0 (0 %) 0 (0 %)
Therapyb
 Digital 0 (0 %) 0 (0 %) 0 (0 %) 3 (3.3 %) 0 (0 %) 2 (28.6 %) 5 (26.3 %)
 ACEi 3 (37.5 %)h 4 (30.8 %)h 14 (82.4 %) 7 (77.8 %) 0 (0 %) 3 (42.9 %) 15 (78.9 %)
 Bblock 1 (12.5 %) 1 (7.7 %) 12 (70.6 %) 9 (100 %) 2 (3.4 %) 6 (85.7 %) 19 (100 %)
 ARB 0 (0 %) 3 (23.1 %)i 2 (11.8 %) 2 (22.2 %) 0 (0 %) 3 (42.9 %) 4 (21.1 %)
 Ca++block 0 (0 %) 1 (7.7 %) 1 (5.9 %) 1 (11.1 %) 0 (0 %) 0 (0 %) 1 (5.3 %)
 Diuretics 3 (37.5 %)j 2 (18.2 %)j 7 (46.7 %) 5 (100 %) 0 (0 %) 2 (40 %) 12 (85.7 %)
 Aldost. Ant. 0 (0 %) 0 (0 %) 8 (47.1 %) 6 (66.7 %) 0 (0 %) 5 (71.4 %) 12(63.2 %)
Hemodynamics
 HR (bpm) 63.3 ± 4.1 61.9 ± 11.7k 63.7 ± 10.9 69.4 ± 9.7 71.1 ± 11.0 64.6 ± 12.4 78.6 ± 15.4
 SAP (mmHg) 132.0 ± 12.1 122.5 ± 12.3 122.4 ± 15.5 111.4 ± 18.0 122.4 ± 11.7 118.0 ± 28.5 121.7 ± 15.6
 DAP (mmHg) 79.1 ± 2.7 73.9 ± 12.7 74.0 ± 11.5 70.1 ± 12.6 74.6 ± 12.8 70.6 ± 12.8 79.5 ± 15.0
  1. BS body surface, BMI body mass index, SAH systemic arterial hypertension, DM diabetes mellitus, DLP dyslipidemia, FC CHF NYHA functional class of congestive heart failure, NYHA New York Heart Association, ACEi inhibitor of angiotensin converting enzyme, β block beta blocker; ARB angiotensin II receptor blocker, Ca ++ block calcium channel blocker; Aldost Ant aldosterone antagonist, HR heart rate, SAP systolic arterial pressure, DAP diastolic arterial pressure
  2. aContinuous variables expressed as mean ± SD. bCategorical variables expressed as frequency (proportion)
  3. cTukey test, p < 0.001, vs. C1
  4. dTukey; Ch1A, Ch1B p = 0.03 and p = 0.04, vs. C1
  5. eFisher’s exact test; Ch1A and Ch1B, p < 0.001, vs. C1
  6. fFisher’s exact test; Ch1A and Ch1B, p = 0.03; vs. C1
  7. gFisher’s exact test; Ch1A and Ch1B, p < 0.001, vs. C1
  8. hFisher’s exact test; Ch1A and Ch1B, p < 0.001, vs. C1
  9. iFisher’s exact test, p = 0.04, vs. C1
  10. jFisher’s exact test; Ch1A and Ch1B, p = 0.01, vs. C1
  11. kTukey test, p < 0.02, vs. C1